Todos Medical Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TOMDF research report →
Price Chart
About the company
Todos Medical Ltd. operates as an in vitro diagnostics company, concentrating on the creation and commercialization of blood tests for the early detection of cancer and Alzheimer's disease, primarily serving the United States market. The company's innovative approaches to cancer diagnostics include the Total Biochemical Infrared Analysis (TBIA), a proprietary screening technology that uses peripheral blood spectroscopy to investigate cancer's effects on the immune system.
- CEO
- Gerald E. Commissiong
- IPO
- 2017
- Employees
- 7
- HQ
- Tel Aviv, TA, IL
Get TickerSpark's AI analysis on TOMDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.08K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -4.08
- Div Yield
- 0.00%
- Gross Margin
- 56.01%
- Op Margin
- -126.68%
- Net Margin
- -324.81%
- ROE
- 83.70%
- ROIC
- -243.76%
Latest fiscal year · YoY change
- Revenue
- $7.70M-37.1%
- Gross Profit
- $4.31M-1.7%
- Op Income
- $-9,748,000
- Net Income
- $-24,994,000+42.3%
- EPS
- $-0.02+72.5%
- OCF Growth
- +75.8%
- FCF Growth
- +77.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.89
- RSI (14)
- 52
- Avg Volume
- 37.10K
No earnings-call transcripts are available for TOMDF yet.
- Free Float
- 77.3%
- Shares Outstanding
- 1.41B
- Float Shares
- 1.09B
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 28, 23 | COMMISSIONG GERALD | buy | 5,000,000 |
| Aug 24, 22 | COMMISSIONG GERALD | buy | 1,000,000 |
| Jun 30, 21 | COMMISSIONG GERALD | buy | 1,051,480 |
| Apr 1, 21 | Strategic Investment Holdings, LLC | sell | 150,000 |
| Apr 1, 21 | Strategic Investment Holdings, LLC | sell | 100,000 |
| Apr 1, 21 | Strategic Investment Holdings, LLC | sell | 100,000 |
| Apr 1, 21 | Strategic Investment Holdings, LLC | sell | 98,300 |
| Apr 5, 21 | Strategic Investment Holdings, LLC | sell | 1,149,425 |
| Apr 5, 21 | Strategic Investment Holdings, LLC | sell | 1,724,139 |
| Jul 7, 20 | Strategic Investment Holdings, LLC | buy | 18,608,113 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TOMDF coverage
Recent articles, reports, and earnings notes.
No research on TOMDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TOMDF report →Todos Med (OTCMKTS:TOMDF) and Aclarion (NASDAQ:ACON) Head-To-Head Survey
defenseworld.net · Mar 28
Reviewing Todos Med (OTCMKTS:TOMDF) & Auna (NYSE:AUNA)
defenseworld.net · Mar 27
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
defenseworld.net · Dec 28
Todos Medical Announces Insolvency Proceedings in Israel
globenewswire.com · Dec 22
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
globenewswire.com · Sep 26
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
globenewswire.com · Aug 30
Todos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic test
proactiveinvestors.com · Mar 28
Todos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patients
proactiveinvestors.com · Mar 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.